Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ida Robertsen

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|December 12, 2019
Generic drugs – not as equivalent as we think?Karsten Midtvedt, Ida Robertsen, Anders Åsberg
Transplantation|August 9, 2017
How to Report and Interpret Bioequivalence Data in Solid Organ Transplant RecipientsAnders Åsberg, Ida Robertsen, Karsten Midtvedt
British Journal of Clinical Pharmacology|May 31, 2019
Why dose adjust systemic exposure when looking for associations with adverse events in tacrolimus-treated transplant recipients?Ida Robertsen, Jean-Baptiste Woillard, Anders Åsberg
Pharmaceutics|April 28, 2023
A Method for Evaluating Robustness of Limited Sampling Strategies-Exemplified by Serum Iohexol Clearance for Determination of Measured Glomerular Filtration RateMarkus Hovd, Ida Robertsen, Jean-Baptiste Woillard, et al.
European Journal of Clinical Pharmacology|September 13, 2022
Response to: "Utility of endogenous 4β-hydroxycholesterol as a biomarker to assess cytochrome P 450 3A (CYP3A) activity: not quite ready for prime time"Kine Eide Kvitne, Kristine Hole, Espen Molden, et al.
Clinical Pharmacokinetics|March 21, 2018
A Limited Sampling Strategy to Estimate Exposure of Everolimus in Whole Blood and Peripheral Blood Mononuclear Cells in Renal Transplant Recipients Using Population Pharmacokinetic Modeling and Bayesian EstimatorsIda Robertsen, Jean Debord, Anders Åsberg, et al.
Therapeutic Drug Monitoring|November 19, 2024
Implementation of Volumetric Finger-Prick Self-Sampling for Therapeutic Drug Monitoring of Immunosuppressants After Kidney Transplantation: Lessons Learned From the PracticeNils Tore Vethe, Anders Åsberg, Stein Bergan, et al.
Therapeutic Drug Monitoring|January 8, 2015
Closer to the Site of Action: Everolimus Concentrations in Peripheral Blood Mononuclear Cells Correlate Well With Whole Blood ConcentrationsIda Robertsen, Nils Tore Vethe, Karsten Midtvedt, et al.
Therapeutic Drug Monitoring|September 4, 2019
Tacrolimus Area Under the Concentration Versus Time Curve Monitoring, Using Home-Based Volumetric Absorptive Capillary MicrosamplingMarte T Gustavsen, Karsten Midtvedt, Nils T Vethe, et al.
Therapeutic Drug Monitoring|April 10, 2025
Development and Clinical Validation of a Volumetric Absorptive Capillary Microsampling Method for Quantification of Mycophenolic Acid and Mycophenolic Acid Glucuronide in Kidney Transplant RecipientsOle Martin Drevland, Eline Skadberg, Lan Anh Tran, et al.
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|December 12, 2019
Generic drugs – not as equivalent as we think?Karsten Midtvedt, Ida Robertsen, Anders Åsberg
Transplantation|August 9, 2017
How to Report and Interpret Bioequivalence Data in Solid Organ Transplant RecipientsAnders Åsberg, Ida Robertsen, Karsten Midtvedt
British Journal of Clinical Pharmacology|May 31, 2019
Why dose adjust systemic exposure when looking for associations with adverse events in tacrolimus-treated transplant recipients?Ida Robertsen, Jean-Baptiste Woillard, Anders Åsberg
Pharmaceutics|April 28, 2023
A Method for Evaluating Robustness of Limited Sampling Strategies-Exemplified by Serum Iohexol Clearance for Determination of Measured Glomerular Filtration RateMarkus Hovd, Ida Robertsen, Jean-Baptiste Woillard, et al.
European Journal of Clinical Pharmacology|September 13, 2022
Response to: "Utility of endogenous 4β-hydroxycholesterol as a biomarker to assess cytochrome P 450 3A (CYP3A) activity: not quite ready for prime time"Kine Eide Kvitne, Kristine Hole, Espen Molden, et al.
Clinical Pharmacokinetics|March 21, 2018
A Limited Sampling Strategy to Estimate Exposure of Everolimus in Whole Blood and Peripheral Blood Mononuclear Cells in Renal Transplant Recipients Using Population Pharmacokinetic Modeling and Bayesian EstimatorsIda Robertsen, Jean Debord, Anders Åsberg, et al.
Therapeutic Drug Monitoring|November 19, 2024
Implementation of Volumetric Finger-Prick Self-Sampling for Therapeutic Drug Monitoring of Immunosuppressants After Kidney Transplantation: Lessons Learned From the PracticeNils Tore Vethe, Anders Åsberg, Stein Bergan, et al.
Therapeutic Drug Monitoring|January 8, 2015
Closer to the Site of Action: Everolimus Concentrations in Peripheral Blood Mononuclear Cells Correlate Well With Whole Blood ConcentrationsIda Robertsen, Nils Tore Vethe, Karsten Midtvedt, et al.
Therapeutic Drug Monitoring|September 4, 2019
Tacrolimus Area Under the Concentration Versus Time Curve Monitoring, Using Home-Based Volumetric Absorptive Capillary MicrosamplingMarte T Gustavsen, Karsten Midtvedt, Nils T Vethe, et al.
Therapeutic Drug Monitoring|April 10, 2025
Development and Clinical Validation of a Volumetric Absorptive Capillary Microsampling Method for Quantification of Mycophenolic Acid and Mycophenolic Acid Glucuronide in Kidney Transplant RecipientsOle Martin Drevland, Eline Skadberg, Lan Anh Tran, et al.
Pageof 5